Likes Subject
Gamida Cell Announces FDA Acceptance of Biologics License midastouch017 08/01/22 7:44 AM
Thank you. I appreciate the guidance. rwwine 01/23/23 7:27 AM
I am quite sure that once PDUFA action midastouch017 01/23/23 12:08 AM
Thank you sir for sharing. Do you rwwine 01/22/23 8:13 AM
Naturally the offering is already in the works (sigh) midastouch017 01/21/23 7:36 AM
In retrospect it was a mistake letting Lonza midastouch017 01/20/23 11:41 AM
Is that good or bad, beyond the fact murocman 01/20/23 10:05 AM
Item 8.01 Other Events. midastouch017 01/19/23 11:06 PM
Article published in Hebrew and Google auto-translated: midastouch017 12/29/22 12:14 PM
I would agree with Midas. Spideyboy 12/14/22 3:53 AM
Gamida Cell Announces Closing of $25 Million Financing midastouch017 12/12/22 8:09 AM
Does that explain the struggling SP? I Itstime15 12/11/22 10:37 AM
I am sure NOT or rather i should say midastouch017 12/11/22 1:03 AM
With this current Enterprise value (EV) of ~$95 rwwine 12/09/22 2:47 PM
Gamida Cell to Present Corporate Highlights at Multiple midastouch017 11/23/22 10:51 AM
Gamida Cell Provides Regulatory Update on Omidubicel midastouch017 11/22/22 12:50 AM
Gamida Cell Ltd. (GMDA)Q3 2022 Earnings Call Transcript midastouch017 11/14/22 11:21 AM
Gamida Cell Reports Third Quarter 2022 Financial Results midastouch017 11/14/22 8:01 AM
Gamida Cell Q3 2022 Earnings Preview midastouch017 11/13/22 10:18 AM
As much as i am pleased with today's action, midastouch017 11/11/22 2:20 PM
Getting some buying on volume here. Might murocman 11/11/22 11:51 AM
Gamida Cell to Present Corporate Highlights at the midastouch017 11/10/22 8:09 AM
GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising midastouch017 11/07/22 8:15 AM
Gamida Cell Announces the Date of Its Third midastouch017 11/07/22 8:13 AM
Gamida Cell Announces Omidubicel Data To Be Presented midastouch017 11/03/22 9:19 AM
Gamida Cell to Present Corporate Highlights at 2022 midastouch017 10/10/22 7:21 AM
Company officials buying stock midastouch017 10/05/22 1:14 PM
Company officials buying stock midastouch017 10/05/22 1:14 PM
Clinical Trial Saves Leukemia Patient midastouch017 10/04/22 10:32 AM
Gamida Cell gains on long-term data for blood midastouch017 09/29/22 11:45 AM
Long-Term Data from Omidubicel Phase 3 Trial Demonstrates midastouch017 09/29/22 8:26 AM
Gamida Cell Announces Pricing of Approximately $20 Million midastouch017 09/28/22 8:06 AM
Gamida Cell shares slide after stock offering midastouch017 09/27/22 11:55 PM
Gamida Cell Appoints Abigail L. Jenkins as President midastouch017 09/19/22 7:29 AM
Gamida Cell Ltd. (NASDAQ:GMDA) Receives $14.17 Consensus Target midastouch017 09/15/22 8:29 AM
Gamida Cell Presents Data Demonstrating the Impact of midastouch017 09/12/22 8:20 AM
Thank you sir!! Definitely plan on adding rwwine 09/04/22 11:34 AM
I envy you for your entry point price! midastouch017 08/31/22 12:38 AM
Started a position in GMDA today. Been rwwine 08/30/22 3:09 PM
https://twitter.com/GamidaCellTx/status/1562447195148001280 midastouch017 08/24/22 10:45 AM
Gamida Cell midastouch017 08/23/22 8:07 AM
Gamida Cell (NASDAQ:GMDA – Get Rating) had its midastouch017 08/18/22 8:46 AM
JMP Securities Sticks to Their Buy Rating for midastouch017 08/16/22 8:00 AM
Gamida Cell Ltd. (GMDA) Q2 2022 Earnings Call Transcript midastouch017 08/16/22 12:51 AM
Gamida Cell Reports Second Quarter 2022 Financial Results midastouch017 08/15/22 7:48 AM
Gamida Cell Q2 2022 Earnings Preview midastouch017 08/12/22 1:30 PM
2.9900+0.3500 (+13.2576%) midastouch017 08/11/22 9:56 AM
Gamida Cell Ltd. (GMDA): Ready For An Explosive midastouch017 08/11/22 12:47 AM
2.6550+0.1950 (+7.9268%) midastouch017 08/10/22 1:55 PM
Gamida Cell Announces Dosing of First Patient in midastouch017 08/10/22 7:57 AM
2.4600+0.2900 (+13.36%) midastouch017 08/10/22 4:38 AM
Likes Subject

midastouch017
01/23/23 12:08 AM
rwwine
01/22/23 8:13 AM
midastouch017
01/20/23 11:41 AM
murocman
01/20/23 10:05 AM
midastouch017
01/19/23 11:06 PM
Spideyboy
12/14/22 3:53 AM
Itstime15
12/11/22 10:37 AM
midastouch017
12/11/22 1:03 AM
midastouch017
11/13/22 10:18 AM
midastouch017
11/11/22 2:20 PM
murocman
11/11/22 11:51 AM
midastouch017
11/07/22 8:13 AM
midastouch017
10/05/22 1:14 PM
midastouch017
10/05/22 1:14 PM
midastouch017
10/04/22 10:32 AM
midastouch017
09/29/22 11:45 AM
midastouch017
09/27/22 11:55 PM
midastouch017
08/31/22 12:38 AM
rwwine
08/30/22 3:09 PM
midastouch017
08/23/22 8:07 AM
midastouch017
08/18/22 8:46 AM
midastouch017
08/16/22 8:00 AM
midastouch017
08/12/22 1:30 PM
midastouch017
08/11/22 9:56 AM
midastouch017
08/11/22 12:47 AM
midastouch017
08/10/22 1:55 PM
midastouch017
08/10/22 7:57 AM
midastouch017
08/10/22 4:38 AM

Gamida Cell Ltd. (GMDA)

Followers
13
Posters
18
Posts (Today)
0
Posts (Total)
454
Created
05/09/19
Type
Free
Moderators midastouch017

 
Gamida Cell Ltd., a clinical stage biopharmaceutical company, focuses on developing cell therapies to cure cancer, and rare and serious hematologic diseases. The company's lead product candidate is NiCord, a nicotinamide (NAM)-expanded cord blood cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II studies in patients with severe aplastic anemia. It is also developing NAM-NK, an innate immunotherapy, which is in Phase I studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel.
 

Gamida Cell Ltd.




 

Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Most Liked Posts
(Last 30 Days)
New Post